Logan Corey, John J Wallbillich, Sharon Wu, Alex Farrell, Kurt Hodges, Joanne Xiu, Chadi Nabhan, Anthony Guastella, Mira Kheil, Radhika Gogoi, Ira Winer, Sudeshna Bandyopadhyay, Marilyn Huang, Nathaniel Jones, Annelise Wilhite, Anthony Karnezis, Premal Thaker, Thomas J Herzog, Matthew Oberley, William Michael Korn, Alex Vezina, Robert Morris, Rouba Ali-Fehmi
Vulvar squamous cell cancer (VSC) accounts for 90% of vulvar cancers. Next-generation sequencing studies of VSC imply human papillomavirus (HPV) and p53 status play separate roles in carcinogenesis and prognosis. We sought to describe the genomic landscape and analyze the immunologic profiles of VSC with respect to HPV and p53 status. A total of 443 VSC tumors underwent tumor profiling. Next-generation sequencing was performed on genomic DNA isolated from formalin-fixed paraffin-embedded tumor samples. PD-L1, microsatellite instability were tested by fragment analysis, IHC, and next-generation sequencing...
September 1, 2023: International Journal of Gynecological Pathology